# Kickfund

> Kickfund is a VC fund in Basel backing Biotechnology, Health Care and Manufacturing. See 49 investments, check sizes, portfolio. Updated Aug 2026.

- Type: VC Fund
- Location: Basel, Switzerland
- Total investments: 49
- Last investment: Jul 2026
- Lead investor: 16%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/kickfund-ch/
- X (Twitter): https://twitter.com/kickfund_CH
- Website: https://www.kickfund.ch/

Kickfund is a VC fund in Basel focused on Biotechnology and Health Care. Kickfund invests in pre-seed and seed stage deep-tech startups in Switzerland that have won the Venture Kick competition. The fund, based in Luxembourg, aims to support these startups through their early equity rounds without taking a leading position. Kickfund reinvests into the Swiss innovation ecosystem to foster growth and global visibility forSwiss startups. The fund focuses on generating strong financial returns while empowering and connecting entrepreneurs within the Swiss startup ecosystem.

## Round sizes

| Stage | Round size |
| --- | --- |
| Seed | $1.1M–$5.7M |
| Pre-Seed | $335k–$4M |
| Convertible Note | $110k–$118k |

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Biotechnology | 9 | 18% |
| Health Care | 8 | 16% |
| Manufacturing | 8 | 16% |
| Renewable Energy | 6 | 12% |
| Medical | 5 | 10% |

61 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 27 | 55% |
| Pre-Seed | 11 | 22% |
| Convertible Note | 5 | 10% |
| Series A | 2 | 4% |
| Venture - Series Unknown | 2 | 4% |

6 stages tracked in total.

### Country

| Country | Investments | Share |
| --- | --- | --- |
| Switzerland | 44 | 90% |
| Germany | 1 | 2% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Immitra Bio | At Immitra Bio, we are developing a unique genetic medicine platform that combines two of the most powerful biomedical technologies: hematopoietic stem cells (HSCs) and CRISPR-Cas9 gene editing. Our novel technique allows for precise and long-lasting gene alterations within blood stem cells, resulting in transformational treatments for uncommondiseases with significant unmet medical needs. | $2.8M | Pre-Seed | Jul 21, 2026 |  |
| Carewell | Carewell is influencing the way people work in healthcare by providing flexible digital solutions tailored to their specific needs. | $1.9M | Seed | Jul 03, 2026 |  |
| BLEEDnFIRE Therapeutics | BLEEDnFIRE is a pioneering innovator in siRNA-based therapies for hemophilia. Its mission is to transform patient care and enhance the quality of life through targeted, effective, and novel treatments |  | Grant | May 27, 2026 |  |
| Cosaic | Cultivated Biosciences is a Food Production Company. | $6M | Seed | Apr 21, 2026 |  |
| SolidWatts | SolidWatts enable the electrification of power-hungry industrial processes that require heat to fulfill a process. | $2.3M | Seed | Mar 25, 2026 |  |
| Seprify | Impossible Materials envisions future customers consuming more sustainable products produced in a circular economy. They contribute to this future by selling cellulose-based products to businesses. Plant-based cellulose white pigment and opacifier solutions have been developed for a variety of industries. | $15.6M | Series A | Mar 10, 2026 |  |
| Clee Medical | Clee Medical believes the rapid growth of neurotech is constrained by inefficiencies in surgical tools and techniques. |  | Seed | Feb 25, 2026 |  |
| Ionic Wind Technologies | Ionic wind technologies, which use an internationally patented concept, alter the way airflow is generated. Instead of conventional rotating machinery, we move air with electric fields. | $2.1M | Pre-Seed | Dec 15, 2025 |  |
| Aukera Therapeutics | Aukera Therapeutics is a biotech company that develops novel therapeutics for patients suffering from mTOR protein-related diseases such as cancer and neurogenerative diseases. Aukera Therapeutics is a spin-off from the Biozentrum of the University of Basel. | $5.7M | Seed | Dec 11, 2025 |  |
| BTRY | BTRY is a spin-off of EMPA and ETH and is developing the industry's first energy-dense solid-state battery, using sophisticated semiconductor manufacturing technologies. | $5.7M | Seed | Nov 06, 2025 |  |

10 of 49 investments shown.

## Co-investors
- [Venture Kick](https://shizune.co/investors/profile/venturekick) — VC Fund, 17 deals together
- [Zürcher Kantonal Bank](https://shizune.co/investors/profile/z%C3%BCrcher-kantonalbank) — VC Fund, 13 deals together
- [SICTIC](https://shizune.co/investors/profile/sictic) — VC Fund, 9 deals together
- [HTGF (High-Tech Gruenderfonds)](https://shizune.co/investors/profile/high-tech-gr%C3%BCnderfonds) — VC Fund, 4 deals together
- [CADFEM](https://shizune.co/investors/profile/cadfem-82f3) — VC Fund, 3 deals together
- [COREangels Climate](https://shizune.co/investors/profile/coreangels-climate) — VC Fund, 3 deals together

## Similar investors

### Similar industry
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund
- [ARCH Venture Partners](https://shizune.co/investors/profile/arch-venture-partners) — VC Fund
- [OrbiMed](https://shizune.co/investors/profile/orbimed-advisors) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

### Similar country
- [SICTIC](https://shizune.co/investors/profile/sictic) — VC Fund
- [Zürcher Kantonal Bank](https://shizune.co/investors/profile/z%C3%BCrcher-kantonalbank) — VC Fund
- [Foundation for Innovation and Technology (FIT)](https://shizune.co/investors/profile/foundation-pour-l-innovation-technologique) — VC Fund

## Featured in investor lists
- [All Investors in Switzerland](https://shizune.co/investors/investors-switzerland)
- [All VC Funds in Switzerland](https://shizune.co/investors/vc-funds-switzerland)
- [Climate Investors in Switzerland](https://shizune.co/investors/climate-investors-switzerland)
- [Climate VC Funds in Switzerland](https://shizune.co/investors/climate-vc-funds-switzerland)
- [Manufacturing Investors in Switzerland](https://shizune.co/investors/manufacturing-investors-switzerland)
- [Manufacturing VC Funds in Switzerland](https://shizune.co/investors/manufacturing-vc-funds-switzerland)

## FAQ

### What does Kickfund invest in?

Kickfund invests primarily in Biotechnology, Health Care and Manufacturing startups, most often at Seed and Pre-Seed stage. Most of the 49 investments tracked by Shizune back companies in Switzerland. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### What is Kickfund's check size?

Kickfund typically joins rounds of $1.1M–$5.7M at Seed, $335k–$4M at Pre-Seed and $110k–$118k at Convertible Note. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Kickfund participates in.

### When did Kickfund last invest?

The most recent investment recorded for Kickfund closed in Jul 2026. Shizune tracks 49 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co